Annual Total Assets
$240.44 M
-$117.73 M-32.87%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual total assets is $240.44 million, with the most recent change of -$117.73 million (-32.87%) on December 31, 2023.
- During the last 3 years, KPTI annual total assets has fallen by -$72.61 million (-23.20%).
- KPTI annual total assets is now -32.87% below its all-time high of $358.17 million, reached on December 31, 2022.
Performance
KPTI Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$189.48 M
-$24.50 M-11.45%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly total assets is $189.48 million, with the most recent change of -$24.50 million (-11.45%) on September 30, 2024.
- Over the past year, KPTI quarterly total assets has dropped by -$24.50 million (-11.45%).
- KPTI quarterly total assets is now -54.47% below its all-time high of $416.14 million, reached on March 31, 2020.
Performance
KPTI Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
KPTI Total Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -32.9% | -11.4% |
3 y3 years | -23.2% | -25.4% |
5 y5 years | -29.5% | -36.4% |
KPTI Total Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -32.9% | at low | -47.1% | at low |
5 y | 5-year | -32.9% | at low | -54.5% | at low |
alltime | all time | -32.9% | >+9999.0% | -54.5% | >+9999.0% |
Karyopharm Therapeutics Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $189.48 M(-11.5%) |
Jun 2024 | - | $213.98 M(+4.7%) |
Mar 2024 | - | $204.46 M(-15.0%) |
Dec 2023 | $240.44 M(-32.9%) | $240.44 M(-10.9%) |
Sep 2023 | - | $269.96 M(-9.4%) |
Jun 2023 | - | $297.83 M(-8.6%) |
Mar 2023 | - | $325.80 M(-9.0%) |
Dec 2022 | $358.17 M(+17.3%) | $358.17 M(+54.9%) |
Sep 2022 | - | $231.24 M(-9.8%) |
Jun 2022 | - | $256.48 M(-12.8%) |
Mar 2022 | - | $294.03 M(-3.7%) |
Dec 2021 | $305.31 M(-2.5%) | $305.31 M(+20.2%) |
Sep 2021 | - | $254.09 M(-11.3%) |
Jun 2021 | - | $286.57 M(+4.2%) |
Mar 2021 | - | $274.91 M(-12.2%) |
Dec 2020 | $313.05 M(+6.1%) | $313.05 M(-7.3%) |
Sep 2020 | - | $337.59 M(-11.2%) |
Jun 2020 | - | $380.01 M(-8.7%) |
Mar 2020 | - | $416.14 M(+41.1%) |
Dec 2019 | $294.96 M(-13.5%) | $294.96 M(-0.9%) |
Sep 2019 | - | $297.75 M(+25.1%) |
Jun 2019 | - | $238.10 M(-17.1%) |
Mar 2019 | - | $287.21 M(-15.8%) |
Dec 2018 | $341.19 M | $341.19 M(+55.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2018 | - | $219.99 M(-14.3%) |
Jun 2018 | - | $256.59 M(+75.3%) |
Mar 2018 | - | $146.37 M(-18.8%) |
Dec 2017 | $180.29 M(-0.1%) | $180.29 M(+10.1%) |
Sep 2017 | - | $163.77 M(-11.8%) |
Jun 2017 | - | $185.75 M(+19.5%) |
Mar 2017 | - | $155.44 M(-13.8%) |
Dec 2016 | $180.38 M(-16.3%) | $180.38 M(-1.8%) |
Sep 2016 | - | $183.62 M(+7.4%) |
Jun 2016 | - | $170.90 M(-11.1%) |
Mar 2016 | - | $192.13 M(-10.8%) |
Dec 2015 | $215.44 M(-2.2%) | $215.44 M(-9.1%) |
Sep 2015 | - | $236.97 M(-10.0%) |
Jun 2015 | - | $263.29 M(-9.8%) |
Mar 2015 | - | $292.04 M(+32.5%) |
Dec 2014 | $220.34 M(+39.3%) | $220.34 M(-6.3%) |
Sep 2014 | - | $235.16 M(+70.8%) |
Jun 2014 | - | $137.68 M(-7.8%) |
Mar 2014 | - | $149.28 M(-5.7%) |
Dec 2013 | $158.23 M(>+9900.0%) | $158.23 M(+183.0%) |
Sep 2013 | - | $55.90 M(-10.5%) |
Jun 2013 | - | $62.48 M(+4665.6%) |
Dec 2012 | $1.31 M(-81.9%) | $1.31 M |
Dec 2011 | $7.22 M | - |
FAQ
- What is Karyopharm Therapeutics annual total assets?
- What is the all time high annual total assets for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual total assets year-on-year change?
- What is Karyopharm Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly total assets year-on-year change?
What is Karyopharm Therapeutics annual total assets?
The current annual total assets of KPTI is $240.44 M
What is the all time high annual total assets for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual total assets is $358.17 M
What is Karyopharm Therapeutics annual total assets year-on-year change?
Over the past year, KPTI annual total assets has changed by -$117.73 M (-32.87%)
What is Karyopharm Therapeutics quarterly total assets?
The current quarterly total assets of KPTI is $189.48 M
What is the all time high quarterly total assets for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly total assets is $416.14 M
What is Karyopharm Therapeutics quarterly total assets year-on-year change?
Over the past year, KPTI quarterly total assets has changed by -$24.50 M (-11.45%)